Nimesulide-induced severe hemolytic anemia and acute liver failure leading to liver transplantation.
We present the case of a 63-year-old woman who had undergone 7 months of treatment with Nimesulide (100 mg/b.i.d.) for symptomatic osteoarthritis. The patient was admitted to our unit with a clinical picture of progressive jaundice over 3 weeks. Clinical and analytical studies revealed acute liver failure, this being confirmed by liver biopsy, which showed submassive necrosis. Serological tests for different viral agents causing hepatitis were all negative. In addition, she presented a picture of severe haemolytic anaemia resistant to several treatments and needed multiple transfusions. Twenty-three days after admission, the patient presented hepatic encephalopathy and received an orthotopic liver transplant on day 25. The evolution after transplantation was good and the patient continues in good health with no evidence of haemolysis almost 2 years later. Liver toxicity due to Nimesulide is well known, but to our knowledge the occurrence of haemolytic anaemia has not been related to this drug previously. For these reasons, Nimesulide has been restricted or removed from the market in several countries in recent months.
Rodrigo
L
L
Gastroenterology Service, Hospital Central de Asturias, Oviedo, Spain.
de Francisco
R
R
Pérez-Pariente
J M
JM
Cadahia
V
V
Tojo
R
R
Rodriguez
M
M
Lucena
Ma I
MI
Andrade
R J
RJ
D000743:Anemia, Hemolytic / Q000139:chemically induced* / Q000150:complications; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D005260:Female; D006801:Humans; D017114:Liver Failure, Acute / Q000139:chemically induced* / Q000150:complications / Q000601:surgery*; D016031:Liver Transplantation; D008875:Middle Aged; D013449:Sulfonamides / Q000009:adverse effects*; D016896:Treatment Outcome
D000894:Anti-Inflammatory Agents, Non-Steroidal; D013449:Sulfonamides; C012655:nimesulide